Pages that link to "Q70060816"

The following pages link to Effect of L-carnitine treatment on lipid metabolism and cardiac performance in chronically diabetic rats (Q70060816):

Displaying 26 items.

• Non-invasive magnetic resonance imaging assessment of myocardial changes and the effects of angiotensin-converting enzyme inhibition in diabetic rats (Q28345082) (← links)
• Magnetic resonance imaging analysis of cardiac cycle events in diabetic rats: the effect of angiotensin-converting enzyme inhibition (Q28345085) (← links)
• L-Carnitine rescues ketamine-induced attenuated heart rate and MAPK (ERK) activity in zebrafish embryos (Q33796903) (← links)
• A critical role for PPARalpha-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: modulation by dietary fat content. (Q34330003) (← links)
• Acetyl-l-carnitine and oxfenicine on cardiac pumping mechanics in streptozotocin-induced diabetes in male Wistar rats (Q34905231) (← links)
• Paradoxical role of lipid metabolism in heart function and dysfunction (Q35655457) (← links)
• Metabolic dysfunction in diabetic cardiomyopathy (Q36930481) (← links)
• Role of carnitine in the regulation of glucose homeostasis and insulin sensitivity: evidence from in vivo and in vitro studies with carnitine supplementation and carnitine deficiency (Q37963740) (← links)
• Effects of amino acid supplementation on myocardial cell damage and cardiac function in diabetes (Q38963800) (← links)
• The relationship of vascular changes to metabolic factors in diabetes mellitus and their role in the development of peripheral nerve complications (Q40579344) (← links)
• Carnitine and its derivatives in cardiovascular disease (Q41667017) (← links)
• Metabolic disturbances in diabetic cardiomyopathy (Q41740242) (← links)
• Melatonin and L-carnitin improves endothelial disfunction and oxidative stress in Type 2 diabetic rats (Q41810219) (← links)
• Decreased plasma carnitine in Type I diabetes mellitus (Q44432877) (← links)
• Effects of L-carnitine treatment on oxidant/antioxidant state and vascular reactivity of streptozotocin-diabetic rat aorta (Q44648361) (← links)
• Exercise training restores abnormal myocardial glucose utilization and cardiac function in diabetes (Q45073998) (← links)
• Effect of L-carnitine on plasma glycemic and lipidemic profile in patients with type II diabetes mellitus (Q45292724) (← links)
• Carnitine supplementation improves myocardial function in hearts from ischemic diabetic and euglycemic rats (Q50109903) (← links)
• Carnitine stimulation of glucose oxidation in the fatty acid perfused isolated working rat heart (Q67754669) (← links)
• Demonstration of disturbed free fatty acid metabolism of myocardium in patients with non-insulin-dependent diabetes mellitus as measured with iodine-123-heptadecanoic acid (Q68006950) (← links)
• Effects of propionyl-L-carnitine and insulin on the electroretinogram, nerve conduction and nerve blood flow in rats with streptozotocin-induced diabetes (Q70990088) (← links)
• L-Propionylcarnitine effects on cardiac carnitine content and function in secondary carnitine deficiency (Q72049922) (← links)
• Diabetic cardiomyopathy (Q72189534) (← links)
• No effect of insulin treatment or glycemic improvement on plasma carnitine levels in type 2 diabetic patients (Q72554833) (← links)
• Long-term effect of acetyl-L-carnitine on myocardial 123I-MIBG uptake in patients with diabetes (Q73632777) (← links)
• Propionyl-L-carnitine effects on postischemic recovery of heart function and substrate oxidation in the diabetic rat (Q73853391) (← links)